pt141 nasal spray side effects PT-141 Bremelanotide (Nasal Spray) PT141 (10 mg) - UK
Description
doi: 10.1016/j.taap.2012.06.005
Oral GLP-1 formulations continue development despite bioavailability challenges
Ab, autoantibody
*May have an adverse effect on activity and attention in children
References Weghofer, A
Dizziness may occur, particularly during the initial treatment period, and may be related to blood pressure changes, dehydration, or hypoglycemia
